Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE.

Literature DB >> 16695860

DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE.

I Sternlier¹, A G Morell, C D Bauer, B Combes, S De Bobes-Sternberg, I H Schein-Berg.

Abstract

Year: 1961 PMID： 16695860 PMCID： PMC290777 DOI： 10.1172/JCI104304

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

26 in total

1. Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration.

Authors: J A BUSH; J P MAHONEY; H MARKOWITZ; C J GUBLER; G E CARTWRIGHT; M M WINTROBE
Journal: J Clin Invest Date: 1955-12 Impact factor: 14.808

2. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.

Authors: I H SCHEINBERG; A G MORELL
Journal: J Clin Invest Date: 1957-08 Impact factor: 14.808

3. Rapid test for hepatolenticular degeneration.

Authors: H A RAVIN
Journal: Lancet Date: 1956-05-19 Impact factor: 79.321

4. Copper transport and excretion in normal subjects and in patients with Laennec's cirrhosis and Wilson's disease: a study with CU64.

Authors: W N JENSEN; H KAMIN
Journal: J Lab Clin Med Date: 1957-02

5. Studies on copper metabolism. XIII. Hepatolenticular degeneration.

Authors: G E CARTWRIGHT; R E HODGES; C J GUBLER; J P MAHONEY; K DAUM; M M WINTROBE; W B BEAN
Journal: J Clin Invest Date: 1954-11 Impact factor: 14.808

6. [Considerations on Wilson's disease; genealogic, clinical, and metabolic investigations on 60 members of one family].

Authors: G HEUYER; A BAUDOIN; H AZIMA; H FAURE; H JEROME; H SCHMITT
Journal: Rev Neurol (Paris) Date: 1953 Impact factor: 2.607

7. Genetic and biochemical aspects of Wilson's disease.

Authors: A G BEARN
Journal: Am J Med Date: 1953-10 Impact factor: 4.965

8. Metabolism of copper in Wilson's disease and in normal subjects; studies with Cu-64.

Authors: C J EARL; M J MOULTON; B SELVERSTONE
Journal: Am J Med Date: 1954-08 Impact factor: 4.965

9. A clinical and biochemical study of hepatolenticular degeneration (Wilson's disease).

Authors: H BICKEL; F C NEALE; G HALL
Journal: Q J Med Date: 1957-10

10. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).

Authors: I H SCHEINBERG; D GITLIN
Journal: Science Date: 1952-10-31 Impact factor: 47.728

14 in total

1. ABSORPTION OF COPPER IN MALABSORPTION SYNDROMES.

Authors: I STERNLIEB; H D JANOWITZ
Journal: J Clin Invest Date: 1964-06 Impact factor: 14.808

2. Studies on the oxidase properties of ceruloplasmin: factors in normal and Wilson's-disease serum affecting oxidase activity.

Authors: J M WALSHE
Journal: J Clin Invest Date: 1963-07 Impact factor: 14.808

3. THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER AND COPPER.

Authors: I Sternlieb; A G Morell; W D Tucker; M W Greene; I H Scheinberg
Journal: J Clin Invest Date: 1961-10 Impact factor: 14.808

4. [Advances in the recognition of heterozygous characteristics in hereditary enzymopathies].

Authors: F LINNEWEH
Journal: Klin Wochenschr Date: 1962-06-01

5. Copper deficiency related myelopathy 40 years following a jejunoileal bypass.

Authors: Shawn Joshi; Mitra McLarney; Benjamin Abramoff
Journal: Spinal Cord Ser Cases Date: 2019-12-16

6. Middle-aged heterozygous carriers of Wilson's disease do not present with significant phenotypic deviations related to copper metabolism.

Authors: G Gromadzka; G Chabik; T Mendel; A Wierzchowska; M Rudnicka; A Czlonkowska
Journal: J Genet Date: 2010-12 Impact factor: 1.166